...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: The problem...as I see it

I was not aware that physicians were doing so - but I am in the UK not the USA. 
I cannot see any justification for prescribing SGLT2 inhibitors to non-diabetics unless a clinical trial has shown it is safe and that it lowers MACE.

Share
New Message
Please login to post a reply